The past and future of haemophilia: diagnosis, treatments, and its complications.
about
Different impact of factor VIII products on inhibitor development?Genome editing for inborn errors of metabolism: advancing towards the clinic.Acquired hemophilia A: a review of recent data and new therapeutic options.Overexpression of factor VIII after AAV delivery is transiently associated with cellular stress in hemophilia A mice.Systemic delivery of factor IX messenger RNA for protein replacement therapyEftrenonacog Alfa: A Review in Haemophilia B.Efficacy and safety of a recombinant factor VIII produced from a human cell line (simoctocog alfa).Elucidation of Factor VIII Activity Pharmacokinetics: A Pooled Population Analysis in Patients With Hemophilia A Treated With Moroctocog Alfa.Tailoring hemostatic therapies to lower inhibitor development in previously untreated patients with severe hemophilia A.Efmoroctocog Alfa: A Review in Haemophilia A.BAY 81-8973 (Octocog Alfa; Kovaltry®): A Review in Haemophilia A.Advances in the treatment of bleeding disorders.Incidence of low-titre factor VIII inhibitors in patients with haemophilia A: meta-analysis of observational studies.New therapies for hemophilia.Coagulation Factor IX (Recombinant), Albumin Fusion Protein (Albutrepenonacog Alfa; Idelvion®): A Review of Its Use in Haemophilia B.Production of recombinant coagulation factors: Are humans the best host cells?Two-incision laparoscopic appendectomy for a severe hemophilia A child patient with coagulation factor VII deficiency: Case report and review of literature.Repeated Diffuse Alveolar Hemorrhage in a Patient with Hemophilia B.Oral Tolerance Induction in Hemophilia B Dogs Fed with Transplastomic Lettuce.Analyses of the FranceCoag cohort support immunogenicity differences among one plasma-derived and two recombinant factor VIII brands in boys with severe hemophilia A.Timing and severity of inhibitor development in recombinant versus plasma-derived factor VIII concentrates: a SIPPET analysis.Nonacog Beta Pegol: A Review in Haemophilia B.Management of Hemophilia in Older Patients.Modern Treatments of Haemophilia: Review of Cost-Effectiveness Analyses and Future Directions.Trenonacog alfa for prophylaxis, on-demand and perioperative management of hemophilia B.Total Hip Arthroplasty in Hemophilia Patients: A Mid-term to Long-term Follow-up.Vaccinations are not associated with inhibitor development in boys with severe haemophilia A.Molecular mechanisms of missense mutations that generate ectopic N-glycosylation sites in coagulation factor VIII.Inhibition of Tissue Factor Pathway Inhibitor (TFPI) as a Treatment for Haemophilia: Rationale with Focus on Concizumab.Implementing emicizumab in hemophilia inhibitor management: emicizumab should be prescribed after tolerance
P2860
Q28075679-D0F01077-1F3B-489C-95E7-906363B6A297Q36290952-D457EEDA-739D-44FC-A8BA-27F6C6A36D93Q36356147-8DE2BC6C-A580-4A21-A7C5-E70669358C62Q37292357-298E6574-55B8-4394-9150-11AFAEA4A2FDQ37695999-1AFB3F6A-8F6D-40E4-950D-26AFD40154C4Q38711095-C55539A4-3F46-48F4-85EB-F9998D4FDEC7Q38720560-B6DB18E8-9DC7-4DC0-B192-C2A25D532679Q38822601-0590B440-AB35-4DC2-AF2C-D43B971A3535Q38828174-6A0B0516-0814-4A98-BCC3-7FAA5E4760B9Q38917306-6814CCD9-4C44-469E-9736-981890D42A5FQ38941572-44337DCD-78BD-4C4A-B769-61E527731C56Q38945123-BB96A4CA-C22C-4FCC-9DEE-0CBB8462C0AAQ38950767-E214A00C-124C-4D2B-A785-D9B0258B1A4DQ39027887-F8A3753D-206D-4EB1-9F41-C8C6CAC053BAQ39042380-10123D7D-FB46-4082-99F1-6FDC637075F4Q39170433-A5665559-B113-476E-A739-3BEAE486E66FQ41922244-8DB3A85D-4457-4DC1-8E7E-4E82A96B1FFEQ42090919-C04DA567-9D9B-48CD-A677-8215B3B94D84Q45864205-995ED139-6785-4A99-AAC4-A48997DF4C52Q45873084-5B6468C5-DA71-419D-8779-39946CF1D720Q45873688-20C70CB4-5E3D-4F57-92CC-D490BBBE9C74Q45874270-A8E1BD3D-3D0C-4C95-A3F7-2E466326EB27Q45874801-6254DCC7-BAE3-42CD-88A8-2CBE33BD3B2AQ45874959-DBB5F40A-6867-473F-B242-284643F2F5B1Q45874991-FD10A705-9E08-4102-8B62-2A8E42B56B17Q45875066-414348F3-CAD5-422F-8257-1E92DB250972Q45875860-980B82B7-5B38-4D74-BFEE-C2CE655D1555Q52378729-843709FB-5248-4E40-AB52-E1E640E0AC12Q55346403-2164D2F6-2093-47DB-89F9-B494172F0327Q57795848-84ADF024-7CCD-4128-A630-669C7B70345F
P2860
The past and future of haemophilia: diagnosis, treatments, and its complications.
description
2016 nî lūn-bûn
@nan
2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
The past and future of haemophilia: diagnosis, treatments, and its complications.
@ast
The past and future of haemophilia: diagnosis, treatments, and its complications.
@en
The past and future of haemophilia: diagnosis, treatments, and its complications.
@nl
type
label
The past and future of haemophilia: diagnosis, treatments, and its complications.
@ast
The past and future of haemophilia: diagnosis, treatments, and its complications.
@en
The past and future of haemophilia: diagnosis, treatments, and its complications.
@nl
prefLabel
The past and future of haemophilia: diagnosis, treatments, and its complications.
@ast
The past and future of haemophilia: diagnosis, treatments, and its complications.
@en
The past and future of haemophilia: diagnosis, treatments, and its complications.
@nl
P1433
P1476
The past and future of haemophilia: diagnosis, treatments, and its complications
@en
P2093
Isabella Garagiola
P304
P356
10.1016/S0140-6736(15)01123-X
P407
P577
2016-02-18T00:00:00Z